ST HELENS PHARMACY LIMITED
Get an alert when ST HELENS PHARMACY LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£690k
-43.4% vs 2024
Net assets
£1.3m
+8.9% vs 2024
Employees
156
+48.6% vs 2024
Profit before tax
£852k
+29.6% vs 2024
Net assets
2-year trend · vs Consumer Staples median
Accounts
2-year trend · Δ = latest vs prior filed period · latest reflected 2025-09-30
| Metric | Trend | 2024-09-30 | 2025-09-30 | Δ vs prior |
|---|---|---|---|---|
| Turnover | £19,204,171 | £22,710,610 | +18.3% | |
| Operating profit | £1,284,036 | £1,730,872 | +34.8% | |
| Profit before tax | £657,729 | £852,223 | +29.6% | |
| Net profit | £357,093 | £327,571 | -8.3% | |
| Cash | £1,219,208 | £689,638 | -43.4% | |
| Total assets less current liabilities | £8,488,443 | £13,032,366 | +53.5% | |
| Net assets | £1,152,645 | £1,255,487 | +8.9% | |
| Equity | £1,152,645 | £1,255,487 | +8.9% | |
| Average employees | 105 | 156 | +48.6% | |
| Wages | £2,069,882 | £2,479,589 | +19.8% | |
| Directors' remuneration | £25,140 | £27,383 | +8.9% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-09-30 | 2025-09-30 |
|---|---|---|---|
| Operating margin | 6.7% | 7.6% | |
| Net margin | 1.9% | 1.4% | |
| Return on capital employed | 15.1% | 13.3% | |
| Gearing (liabilities / total assets) | 91.5% | 93.5% | |
| Current ratio | 0.83x | 0.91x | |
| Interest cover | 2.05x | 1.97x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated group
- Auditor
- Hazlewoods LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's ability to continue as a going concern for a period of at least twelve months from when the original financial statements were authorised for issue”
Group structure
- ST HELENS PHARMACY LIMITED · parent
- Sutton Pharmacy Limited 100%
- Mediward Limited 100%
- Four Acre Chem Ltd 100%
- Fishlocks Limited 100%
- Shofin Management Ltd 100%
- Eggborough Pharmacy Limited 100%
- Gateacre Chemists Limited 100%
- Stellar Medical Limited 100%
- Tomlinsons of Lytham Limited 100%
- Exmed Worldwide Limited 100%
- JNP Holdings Limited 100%
- ASP Holdings Limited 100%
- Exmed Investments Limited 100%
Significant events
- “On 1 April 2025, St Helens Pharmacy Limited acquired 100% of the issued share capital of Exmed Worldwide Limited and Tomlinsons of Lytham Limited Group, obtaining control”
- “On 1 April 2025, St Helens Pharmacy Limited acquired trade and certain assets of Greencross Garston”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 0 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BAMFORD, Carl | Director | 2022-01-06 | Jan 1992 | British |
| PAREKH, Jignesh | Director | 2013-10-02 | Jan 1984 | British |
| PATEL, Sameer | Director | 2013-10-02 | Apr 1987 | British |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Jignesh Parekh | Individual | Shares 25–50% (as firm), Voting 25–50% (as firm) | 2016-04-06 | Active |
| Mr Sameer Patel | Individual | Shares 50–75% (as firm), Voting 50–75% (as firm), Appoints directors (as firm) | 2016-04-06 | Active |
Filing timeline
Last 20 of 80 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-07-15 | AA | accounts | Accounts with accounts type group | |
| 2026-02-24 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2026-02-24 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-10-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-08-20 | AA | accounts | Accounts with accounts type group | |
| 2025-04-15 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2025-04-15 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2025-04-15 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2025-04-15 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2025-04-15 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2025-04-15 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2025-04-15 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2025-04-15 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2025-04-15 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2025-04-15 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2025-04-15 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2025-04-15 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2025-04-15 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2025-04-14 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-04-14 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.